Seeking Alpha

Executive summary:

  • PD-Rx Pharmaceuticals available for sale at dirt cheap 2.1x EV/EBIT, 6.7x PE and 1.0x P/B multiples.
  • Exit of McKesson from the dispensing market - its biggest competitor - provides meaningful growth opportunity.
  • PD-Rx has a long history of growth, and is profitable since 1993.


PD-Rx Pharmaceuticals (OTCPK:PDRX) is a distributor of medication to primary care physicians. The medications are delivered prepacked from the company's warehouse so patients don't have to see a pharmacist. PD-Rx owns and operates a secure production and warehouse facility with multiple clean rooms to package the medication, and it has its own IT-staff to maintain the web app that physicians use to prescribe and dispense a large assortment of medications. The...

Only subscribers can access this article, which is part of the PRO research library covering 3,775 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: